British Columbia-based company emtelligent has launched an advanced medical AI platform, called emtelliPro+, to help healthcare professionals access and handle patient data for improved decision-making.
According to emtelligent, healthcare organisations are currently inundated with vast amounts of clinical data, with nearly 80% being unstructured and scattered across various formats and departments.
Go deeper with GlobalData
The new platform aims to address this issue by optimising the use of healthcare organisations’ data, providing them a comprehensive view of patient health, membership plans, and population groups.
It leverages emtelligent’s large language model (LLM) to equip healthcare professionals with the tool they require for easily accessing relevant patient information to make more precise and safe decisions in complex use cases.
The platform’s capabilities extend to offering health insurance carriers a detailed perspective on member health and risk, a task traditionally reliant on manual chart reviews.
See Also:
Health systems and electronic health record (EHR) platforms can utilise emtelliPro+ to boost quality performance and workforce productivity.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe platform provides instant and accurate patient medical history summaries, which can speed up the overall care transitions and pinpoint crucial care and coding gaps, noted the vendor.
For pharmaceutical industry and clinical research organisations, the platform enables efficient processing of millions of patients for clinical trial recruitment, monitoring real-world evidence, and assessing treatment effectiveness.
emtelligent CEO and co-founder Tim O’Connell said: “As a practicing physician, I understand the critical importance of accuracy and safety in making diagnoses and determinations, and emtelliPro+ represents the next generation of medical AI.
“With a simple and intuitive interface, clinical and business users can quickly get answers and insights about patients and population cohorts, putting the decision in the hands of the expert, while maintaining the auditable, verifiable evidence that’s so critical for our industry.”
The emtelliPro+ platform combines natural language processing and LLM, extensively trained on a wealth of annotated medical data, to deliver actionable insights. The platform promises to enhance care outcomes, reduce costs, increase revenue, and propel research advancements.
emtelligent will showcase this platform at the upcoming HIMSS Global Health Conference & Exhibition (HIMSS24).
